Temporary class drug order on methiopropamine.

Document type
Briefing
Author(s)
Iversen, Les
Publisher
Advisory Council on the Misuse of Drugs
Date of publication
30 September 2016
Subject(s)
Substance Misuse, Health Services
Collection
Social welfare
Material type
Reports

Download (77KB )

This policy briefing recommends that the TCDO for methiopropamine (MPA) is remade for up to a further 12-month period at its expiry (to expire 26 November 2017) to allow  time to gather and consider more evidence to make a substantiated recommendation.The author states that TCDO action and TCDO-related offences remain proportionate and necessary whilst this further evidence is gathered. He considers that TCDO has been effective in halting the problematic proliferation of MPA. However, he cannot substantiate a recommendation for full control under the Misuse of Drugs Act 1971 at this stage due to lack of sufficient evidence to show that the level of misuse is capable of having harmful effects sufficient to constitute a social problem. He claims that to do so would be a disproportionate response to the current evidence available, explaining the scientific and legal reasons for these suggestions and the physiological effects of abuse of MPA.

Related to Substance Misuse

Drug misuse and dependence: UK guidelines on clinical management

Downloadable guidelines on treating people with drug misuse and drug dependence problems

Family drug and alcohol court national unit: independent evaluation: research report

The family drug and alcohol court (FDAC) offers an alternative form of care proceedings for children put at risk of significant…

Fourth addendum to ACMD’s report on synthetic cannabinoids

This addendum recommends revisions to the regulations regarding the scheduling of synthetic cannabinoids. Specifically, they…

More items related to this subject